- Report
- January 2025
- 250 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- January 2025
- 250 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- August 2025
- 150 Pages
Global
From €3397EUR$3,850USD£2,938GBP
- Report
- March 2025
- 150 Pages
Global
From €3397EUR$3,850USD£2,938GBP
€4280EUR$4,850USD£3,701GBP
- Report
- February 2025
- 200 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- April 2025
- 200 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- September 2025
- 197 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- July 2025
- 150 Pages
Global
From €3397EUR$3,850USD£2,938GBP
€4280EUR$4,850USD£3,701GBP
- Report
- August 2025
- 185 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 194 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 194 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 189 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 193 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- April 2025
- 200 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- February 2025
- 200 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- August 2025
- 186 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 197 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 197 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- March 2025
- 180 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- February 2025
- 182 Pages
Global
From €3971EUR$4,500USD£3,434GBP

The Bioactive Compound market is a subset of the biotechnology industry that focuses on the development and production of compounds with biological activity. These compounds are used in a variety of applications, including drug discovery, diagnostics, and therapeutics. Bioactive compounds are typically derived from natural sources, such as plants, animals, and microorganisms, and are often modified to enhance their activity. The market is driven by the increasing demand for new and improved treatments for a variety of diseases, as well as the need for more efficient and cost-effective drug discovery processes.
The Bioactive Compound market is highly competitive, with a number of companies offering a range of products and services. Major players in the market include Merck, Pfizer, Novartis, and Roche. Other notable companies include AbbVie, AstraZeneca, and GlaxoSmithKline. Show Less Read more